LBC
BMY icon

Leigh Baldwin & Co’s Bristol-Myers Squibb BMY Stock Holding History

Leigh Baldwin & Co’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$557K Sell
9,178
-1
-0% -$58 0.36% 70
2025
Q4 		$495K Sell
9,179
-1,416
-13% -$68.1K 0.33% 78
2025
Q3 		$478K Buy
10,595
+1,419
+15% +$66.3K 0.27% 91
2025
Q2 		$425K Sell
9,176
-449
-5% -$22K 0.28% 89
2025
Q1 		$587K Buy
9,625
+182
+2% +$10.6K 0.47% 54
2024
Q4 		$534K Buy
+9,443
New +$528K 0.45% 57

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Leigh Baldwin & Co's BMY Position: Q1 2026 in Review

Leigh Baldwin & Co reduced its Bristol-Myers Squibb (BMY) stake by 0.01% in Q1 2026, selling an estimated $58 and leaving 9,178 shares worth $557K. The position accounts for 0.36% of the portfolio, ranked #70.

Leigh Baldwin & Co first reported a position in BMY in Q4 2024 and has held it in 6 quarters since. The position peaked at $587K in Q1 2025. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Leigh Baldwin & Co held 9,178 shares of Bristol-Myers Squibb worth $557K as of Q1 2026.
  • Leigh Baldwin & Co sold 1 Bristol-Myers Squibb share in Q1 2026, an estimated $58.
  • Bristol-Myers Squibb made up 0.36% of Leigh Baldwin & Co's portfolio in Q1 2026, its #70 holding.
  • Leigh Baldwin & Co first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 6 quarters since.
  • Leigh Baldwin & Co's Bristol-Myers Squibb position peaked at $587K in Q1 2025.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Leigh Baldwin & Co's 13F filing for Q1 2026, filed 20 May 2026.